One-Step 3D Microfluidic Chip Brings Cells Closer to Real Tissues

Why It Matters

The chip bridges the gap between simple 2D assays and complex organ‑on‑chip models, offering more predictive drug‑screening and disease‑research tools without costly fabrication infrastructure.

Key Takeaways

• One-step 3D printing integrates microstructures onto electrodes.
• Enables precise droplet control and rapid spheroid formation.
• Maintains cell viability up to 72 hours in 3D culture.
• Simplifies fabrication, eliminating clean‑room lithography steps.
• Improves drug screening relevance with tissue‑like spheroids.

Pulse Analysis

Traditional cell‑culture methods rely on flat plastic dishes, forcing cells into an artificial two‑dimensional environment that distorts signaling pathways and drug responses. While microfluidic devices have introduced finer control over media exchange and shear stress, most platforms still depend on continuous flow, external pumps, and multi‑step lithography, limiting accessibility for many laboratories. Digital microfluidics, which manipulates discrete droplets with electric fields, offers precise handling but has struggled to provide a truly three‑dimensional niche for cells. The convergence of these challenges created a clear demand for a simple, integrated system that can mimic tissue architecture without complex fabrication.

The University of Macau team answered that demand with a one‑step micro‑nano 3D‑printing process that deposits dielectric layers, confinement fences, and micro‑well arrays directly onto the electrode substrate. This projection stereolithography approach eliminates clean‑room steps and yields three‑dimensional microstructures that guide droplets into predefined wells. Optimized voltage, electrode geometry, and well height enable reliable droplet transport, splitting, and merging across both flat and raised surfaces. Once trapped, cell suspensions self‑assemble into compact spheroids, maintaining high viability for up to 72 hours and reproducing key tissue‑like cell‑cell contacts.

The platform’s ability to generate physiologically relevant spheroids on a low‑cost chip has immediate ramifications for drug screening, where three‑dimensional models better predict efficacy and toxicity than monolayers. Cancer researchers can exploit the controlled microenvironment to study tumor heterogeneity, while tissue‑engineers may use the system as a building block for organ‑on‑chip assemblies. Future iterations aim to lower operating voltages, embed biosensors, and support multi‑cell co‑culture, extending culture duration and complexity. By democratizing advanced 3D cell‑culture technology, the chip could accelerate translational research in labs that lack specialized microfabrication facilities.